310 related articles for article (PubMed ID: 25059655)
1. Impact of FDA Actions, DTCA, and Public Information on the Market for Pain Medication.
Bradford WD; Kleit AN
Health Econ; 2015 Jul; 24(7):859-75. PubMed ID: 25059655
[TBL] [Abstract][Full Text] [Related]
2. Medicare Prescription Drug Plan Formulary Restrictions After Postmarket FDA Black Box Warnings.
Solotke MT; Ross JS; Shah ND; Karaca-Mandic P; Dhruva SS
J Manag Care Spec Pharm; 2019 Nov; 25(11):1201-1217. PubMed ID: 31663461
[TBL] [Abstract][Full Text] [Related]
3. Ethical and Practical Considerations in Removing Black Box Warnings from Drug Labels.
Yeh JS; Sarpatwari A; Kesselheim AS
Drug Saf; 2016 Aug; 39(8):709-14. PubMed ID: 27000800
[TBL] [Abstract][Full Text] [Related]
4. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.
Kim H
Int J Health Policy Manag; 2015 Aug; 4(12):813-21. PubMed ID: 26673465
[TBL] [Abstract][Full Text] [Related]
5. Proposed NSAID package insert labeling.
Food and Drug Administration U.S. Public Health Service
J Pain Palliat Care Pharmacother; 2006; 20(1):49-55. PubMed ID: 16687359
[TBL] [Abstract][Full Text] [Related]
6. FDA boxed warnings: how to prescribe drugs safely.
O'Connor NR
Am Fam Physician; 2010 Feb; 81(3):298-303. PubMed ID: 20112888
[TBL] [Abstract][Full Text] [Related]
7. Atomoxetine use during a period of FDA actions.
Du DT; Zhou EH; Goldsmith J; Nardinelli C; Hammad TA
Med Care; 2012 Nov; 50(11):987-92. PubMed ID: 23047788
[TBL] [Abstract][Full Text] [Related]
8. A continuing black hole? The FDA boxed warning: an appeal to improve its clinical utility.
Matlock A; Allan N; Wills B; Kang C; Leikin JB
Clin Toxicol (Phila); 2011 Jul; 49(6):443-7. PubMed ID: 21591886
[TBL] [Abstract][Full Text] [Related]
9. The Tip of the Iceberg of Misleading Online Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
Mintzes B
Int J Health Policy Manag; 2016 Feb; 5(5):329-31. PubMed ID: 27239883
[TBL] [Abstract][Full Text] [Related]
10. Non-steroidal anti-inflammatory drug administration after coronary artery bypass surgery: utilization persists despite the boxed warning.
Kulik A; Bykov K; Choudhry NK; Bateman BT
Pharmacoepidemiol Drug Saf; 2015 Jun; 24(6):647-53. PubMed ID: 25907164
[TBL] [Abstract][Full Text] [Related]
11. Still the Great Debate - "Fair Balance" in Direct-to-Consumer Prescription Drug Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
Rollins BL
Int J Health Policy Manag; 2016 Feb; 5(4):287-8. PubMed ID: 27239875
[TBL] [Abstract][Full Text] [Related]
12. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
13. Prescribing Antipsychotic Medications to Patients With Dementia: Boxed Warnings and Mitigation of Legal Liability.
Rose RV; Kass JS
Continuum (Minneap Minn); 2019 Feb; 25(1):254-259. PubMed ID: 30707196
[TBL] [Abstract][Full Text] [Related]
14. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
Nemeroff CB; Kalali A; Keller MB; Charney DS; Lenderts SE; Cascade EF; Stephenson H; Schatzberg AF
Arch Gen Psychiatry; 2007 Apr; 64(4):466-72. PubMed ID: 17404123
[TBL] [Abstract][Full Text] [Related]
15. Direct-to-consumer advertising of COX-2 inhibitors: effect on appropriateness of prescribing.
Spence MM; Teleki SS; Cheetham TC; Schweitzer SO; Millares M
Med Care Res Rev; 2005 Oct; 62(5):544-59. PubMed ID: 16177457
[TBL] [Abstract][Full Text] [Related]
16. Black box warnings: what do they mean to pharmacists and patients.
Martin CM; Borgelt L
Consult Pharm; 2012 Jul; 27(7):482-92. PubMed ID: 22910129
[TBL] [Abstract][Full Text] [Related]
17. The Value of the Black Box Warning in Dermatology.
Winterfield L; Vleugels RA; Park KK
J Drugs Dermatol; 2015 Jul; 14(7):660-6. PubMed ID: 26151780
[TBL] [Abstract][Full Text] [Related]
18. Prospective Assessment of Inpatient Boxed Warning Prescriber Adherence.
Kloet MA; Lohr BR; Smithburger PL; Seybert AL; Kane-Gill SL
J Patient Saf; 2017 Mar; 13(1):25-30. PubMed ID: 24647270
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular disease and non-steroidal anti-inflammatory drug prescribing in the midst of evolving guidelines.
Pham TT; Miller MJ; Harrison DL; Lloyd AE; Crosby KM; Johnson JL
J Eval Clin Pract; 2013 Dec; 19(6):1026-34. PubMed ID: 23163341
[TBL] [Abstract][Full Text] [Related]
20. Rates of Nonsteroidal Anti-Inflammatory Drug Use in Patients with Established Cardiovascular Disease: A Retrospective, Cross-Sectional Study from NHANES 2009-2010.
Castelli G; Petrone A; Xiang J; Shrader C; King D
Am J Cardiovasc Drugs; 2017 Jun; 17(3):243-249. PubMed ID: 28063129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
